Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Online Chronic Pain Program Led to Reduced Opioid Dosage—Without an Increase in Pain

Online Chronic Pain Program Led to Reduced Opioid Dosage—Without an Increase in Pain THE BACKLETTER Vol. 38, No. 6, June 2023 Sixty Years of Drug Research Wasted? Or Maybe Not? ecades of research have failed to lay press. Whether it provides a useful per- produce credible evidence that any spective on drugs for acute pain—and wins D drug therapy is effective and safe broad acceptance in the practice of medi- in the treatment of acute low back pain, if a cine—remain to be seen. BackLetter edi- stunning new review and network tors couldn’t find consensus on these ques - meta-analysis is correct. (See definition of tions. (See comments from several experts network meta-analysis below.) below.) Reviews based on network This is a stunning conclusion because it meta-analyses in the back pain field hav - conflicts with the dominant view across en’t had a major influence on clinical prac - medicine. Numerous international evi- tice in the past. dence-based guidelines based on more tra- As mentioned above, the dominant view ditional head-to-head clinical trials and in medicine is that a few drugs—such as meta-analyses have concluded that several NSAIDs—do provide modest pain relief for common medications provide modest relief acute back pain with acceptable safety of acute back pain. (depending on a patient’s http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png BackLetter Wolters Kluwer Health

Online Chronic Pain Program Led to Reduced Opioid Dosage—Without an Increase in Pain

BackLetter , Volume 38 (6) – Jun 1, 2023

Loading next page...
 
/lp/wolters-kluwer-health/online-chronic-pain-program-led-to-reduced-opioid-dosage-without-an-rptZtYKfL6

References (3)

Publisher
Wolters Kluwer Health
Copyright
© 2023 Wolters Kluwer Health, Inc. All rights reserved.
ISSN
0894-7376
eISSN
2161-5179
DOI
10.1097/01.back.0000937388.89475.f3
Publisher site
See Article on Publisher Site

Abstract

THE BACKLETTER Vol. 38, No. 6, June 2023 Sixty Years of Drug Research Wasted? Or Maybe Not? ecades of research have failed to lay press. Whether it provides a useful per- produce credible evidence that any spective on drugs for acute pain—and wins D drug therapy is effective and safe broad acceptance in the practice of medi- in the treatment of acute low back pain, if a cine—remain to be seen. BackLetter edi- stunning new review and network tors couldn’t find consensus on these ques - meta-analysis is correct. (See definition of tions. (See comments from several experts network meta-analysis below.) below.) Reviews based on network This is a stunning conclusion because it meta-analyses in the back pain field hav - conflicts with the dominant view across en’t had a major influence on clinical prac - medicine. Numerous international evi- tice in the past. dence-based guidelines based on more tra- As mentioned above, the dominant view ditional head-to-head clinical trials and in medicine is that a few drugs—such as meta-analyses have concluded that several NSAIDs—do provide modest pain relief for common medications provide modest relief acute back pain with acceptable safety of acute back pain. (depending on a patient’s

Journal

BackLetterWolters Kluwer Health

Published: Jun 1, 2023

There are no references for this article.